White House to Reveal Drug Pricing Agreement with Regeneron
The White House will formally unveil a drug pricing agreement with Regeneron Pharmaceuticals at a Thursday afternoon event, following a post by White House press secretary Karoline Leavitt on X. Regeneron is the last of 17 large pharmaceutical firms contacted by President Donald Trump in July to sign the pricing accords. The company confirmed the a…